Markers of Atherosclerosis: Part 1-Serological Markers
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F19%3A00070966" target="_blank" >RIV/00159816:_____/19:00070966 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/19:00108495
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S1443950618319164?via%3Dihub#" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1443950618319164?via%3Dihub#</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.hlc.2018.06.1057" target="_blank" >10.1016/j.hlc.2018.06.1057</a>
Alternative languages
Result language
angličtina
Original language name
Markers of Atherosclerosis: Part 1-Serological Markers
Original language description
Atherosclerosis is a major contributor to morbidity and mortality worldwide. With therapeutic consequences in mind, several risk scores are being used to differentiate individuals with low, intermediate or high cardiovascular (CV) event risk. The most appropriate management of intermediate risk individuals is still not known, therefore, novel biomarkers are being sought to help re-stratify them as low or high risk. This narrative review is presented in two parts. Here, in Part 1, we summarise current knowledge on serum (serological) biomarkers of atherosclerosis. Among novel biomarkers, high sensitivity C-reactive protein (hsCRP) has emerged as the most promising in chronic situations, others need further clinical studies. However, it seems that a combination of serum biomarkers offers more to risk stratification than either biomarker alone. In Part 2, we address genetic and imaging markers of atherosclerosis, as well as other developments relevant to risk prediction.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/NV17-29701A" target="_blank" >NV17-29701A: Ischemia modified albumin and circulating microRNAs as a new technology for monitoring of tissue ischemia following abdominal aortic vascular surgery</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Heart Lung and Circulation
ISSN
1443-9506
e-ISSN
—
Volume of the periodical
28
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
11
Pages from-to
667-677
UT code for WoS article
000462780100007
EID of the result in the Scopus database
—